Matthew Winton - Net Worth and Insider Trading
Matthew Winton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Winton owns 1 companies in total, including Inozyme Pharma Inc (INZY) .
Click here to see the complete history of Matthew Winton’s form 4 insider trades.
Insider Ownership Summary of Matthew Winton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2023-04-03 | COO |
Matthew Winton Trading Performance
Matthew Winton Ownership Network
Ownership Network List of Matthew Winton
Ownership Network Relation of Matthew Winton
Matthew Winton Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Matthew Winton is the COO of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , See Remarks Henric Bjorn Bjarke , and director & 10 percent owner & See Remarks Axel Bolte .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Matthew Winton made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,281,265 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,114,598 shares were bought by its insiders, resulting in a net purchase of 2,107,075 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Matthew Winton Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Winton. You might contact Matthew Winton via mailing address: C/o Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
